Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line.

Fiala O, Hosek P, Sorejs O, Liska V, Buchler T, Poprach A, Kucera R, Topolcan O, Sedivcova M, Finek J.

J Cancer. 2018 Oct 20;9(22):4255-4262. doi: 10.7150/jca.26217. eCollection 2018.

2.

One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients.

Kosťun J, Pešta M, Sláma J, Slunéčko R, Vlasák P, Bouda J, Novotný Z, Topolčan O, Kučera R, Kulda V, Houfková K, Berezovskiy D, Bartáková A, Presl J.

J Surg Oncol. 2019 Mar;119(3):361-369. doi: 10.1002/jso.25322. Epub 2018 Dec 3.

PMID:
30508294
3.

PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma - A Pilot Study.

Svobodova S, Karlikova M, Topolcan O, Pecen L, Pestova M, Kott O, Treska V, Slouka D, Kucera R.

In Vivo. 2018 Nov-Dec;32(6):1551-1554. doi: 10.21873/invivo.11413.

4.

An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis.

Windrichova J, Kucera R, Fuchsova R, Topolcan O, Fiala O, Svobodova J, Finek J, Slipkova D.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818807466. doi: 10.1177/1533033818807466.

5.

Comprehensive Profiling of Four Base Overhang Ligation Fidelity by T4 DNA Ligase and Application to DNA Assembly.

Potapov V, Ong JL, Kucera RB, Langhorst BW, Bilotti K, Pryor JM, Cantor EJ, Canton B, Knight TF, Evans TC Jr, Lohman GJS.

ACS Synth Biol. 2018 Nov 16;7(11):2665-2674. doi: 10.1021/acssynbio.8b00333. Epub 2018 Oct 29.

PMID:
30335370
6.

Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.

Treska V, Fichtl J, Ludvik J, Bruha J, Liska V, Treskova I, Kucera R, Topolcan O, Lysak D, Skalicky T, Ferda J.

Anticancer Res. 2018 Sep;38(9):5531-5537. doi: 10.21873/anticanres.12888.

PMID:
30194213
7.

A case series describing common radiographic and pathologic patterns of hard metal pneumoconiosis.

Chiarchiaro J, Tomsic LR, Strock S, Veraldi KL, Nouraie M, Sellares J, Lindell KO, Ortiz LA, Sciurba FC, Kucera RF, Yousem SA, Fuhrman CR, Kass DJ, Gibson KF.

Respir Med Case Rep. 2018 Aug 10;25:124-128. doi: 10.1016/j.rmcr.2018.08.006. eCollection 2018.

8.

OPG, OPN, EGF and VEGF Levels at Individual Breslow Score Stages in Malignant Melanoma.

Treskova I, Topolcan O, Windrichova J, Simanek V, Slouka D, Treska V, Kucera R.

Anticancer Res. 2018 Aug;38(8):4907-4911. doi: 10.21873/anticanres.12806.

PMID:
30061268
9.

Stability of total prostate-specific antigen and free prostate-specific antigen after 10 years' storage.

Simanek V, Topolcan O, Karlikova M, Dolejsova O, Fuchsova R, Kinkorova J, Slouka D, Kucera R.

Int J Biol Markers. 2018 Jul 27:1724600818789414. doi: 10.1177/1724600818789414. [Epub ahead of print]

PMID:
30049237
10.

The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6-A Study on 320 Patients After Radical Prostatectomy.

Dolejsova O, Kucera R, Fuchsova R, Topolcan O, Svobodova H, Hes O, Eret V, Pecen L, Hora M.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818787377. doi: 10.1177/1533033818787377.

11.

Detection and Quantification of Carbohydrate-Deficient Transferrin by MALDI-Compatible Protein Chips Prepared by Ambient Ion Soft Landing.

Darebna P, Spicka J, Kucera R, Topolcan O, Navratilova E, Ruzicka V, Volny M, Novak P, Pompach P.

Clin Chem. 2018 Sep;64(9):1319-1326. doi: 10.1373/clinchem.2017.285452. Epub 2018 Jul 12.

PMID:
30002097
12.

Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens.

Kucera R, Bouskila J, Elkrief L, Fink-Jensen A, Palmour R, Bouchard JF, Ptito M.

Sci Rep. 2018 Jun 6;8(1):8689. doi: 10.1038/s41598-018-26826-2.

13.

Perioperative Tumour Marker Levels as Prognostic Factors for Surgical Treatment of Breast Cancer Liver Metastases.

Treska V, Topolcan O, Zoubkova V, Treskova I, Narsanska A, Kucera R.

Anticancer Res. 2018 Jun;38(6):3647-3652. doi: 10.21873/anticanres.12640.

PMID:
29848722
14.

Efficient Synthesis of a Wide-Range Absorbing Azaphthalocyanine Dark Quencher and Its Application to Dual-Labeled Oligonucleotide Probes for Quantitative Real-Time Polymerase Chain Reactions.

Demuth J, Kucera R, Kopecky K, Havlínová Z, Libra A, Novakova V, Miletin M, Zimcik P.

Chemistry. 2018 Jul 5;24(38):9658-9666. doi: 10.1002/chem.201801319. Epub 2018 Jun 7.

PMID:
29683215
15.

Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro.

Sorf A, Hofman J, Kučera R, Staud F, Ceckova M.

Biochem Pharmacol. 2018 Aug;154:10-17. doi: 10.1016/j.bcp.2018.04.013. Epub 2018 Apr 16.

PMID:
29673999
16.

Directed C-H Bond Oxidation of (+)-Pleuromutilin.

Ma X, Kucera R, Goethe OF, Murphy SK, Herzon SB.

J Org Chem. 2018 Jul 6;83(13):6843-6892. doi: 10.1021/acs.joc.8b00462. Epub 2018 May 1.

PMID:
29664634
17.

Follicular fluid levels of anti-Müllerian hormone, insulin-like growth factor 1 and leptin in women with fertility disorders.

Kucera R, Babuska V, Ulcova-Gallova Z, Kulda V, Topolcan O.

Syst Biol Reprod Med. 2018 Jun;64(3):220-223. doi: 10.1080/19396368.2018.1450906. Epub 2018 Mar 29.

PMID:
29595066
18.

Risk factors for failure of continuous positive airway pressure treatment in patients with ostructive sleep apnoea.

Slouka D, Honnerova M, Hosek P, Matas A, Slama K, Landsmanova J, Kucera R.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun;162(2):134-138. doi: 10.5507/bp.2017.056. Epub 2018 Jan 18.

19.

CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer.

Svobodova S, Kucera R, Fiala O, Karlikova M, Narsanska A, Zedníková I, Treska V, Slouka D, Rousarova M, Topolcan O, Finek J.

Anticancer Res. 2018 Jan;38(1):465-469.

PMID:
29277810
20.

Effects of Prenatal Alcohol Exposure on the Visual System of Monkeys Measured at Different Stages of Development.

Harrar V, Elkrief L, Bouskila J, Kucera R, Fink-Jensen A, Bouchard JF, Palmour R, Ptito M.

Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6282-6291. doi: 10.1167/iovs.17-22181.

PMID:
29242902
21.

Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC.

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Stehlik P, Sorejs O, Minarik M, Benesova L, Celer A, Nemcova I, Kucera R, Topolcan O.

Anticancer Res. 2017 Nov;37(11):6469-6476.

PMID:
29061834
22.

A Concise Synthesis of Forskolin.

Hylse O, Maier L, Kučera R, Perečko T, Svobodová A, Kubala L, Paruch K, Švenda J.

Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12586-12589. doi: 10.1002/anie.201706809. Epub 2017 Sep 5.

PMID:
28782270
23.

Laying Waste to Mercury: Inexpensive Sorbents Made from Sulfur and Recycled Cooking Oils.

Worthington MJH, Kucera RL, Albuquerque IS, Gibson CT, Sibley A, Slattery AD, Campbell JA, Alboaiji SFK, Muller KA, Young J, Adamson N, Gascooke JR, Jampaiah D, Sabri YM, Bhargava SK, Ippolito SJ, Lewis DA, Quinton JS, Ellis AV, Johs A, Bernardes GJL, Chalker JM.

Chemistry. 2017 Nov 16;23(64):16219-16230. doi: 10.1002/chem.201702871. Epub 2017 Aug 30.

24.

Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.

Kalfert D, Ludvikova M, Topolcan O, Celakovsky P, Kucera R, Windrichova J, Ludvik J, Skalova K, Kulda V, Pesta M, Plzak J.

Anticancer Res. 2017 Jun;37(6):3281-3286.

PMID:
28551677
25.

Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed.

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Buchler T, Poprach A, Hejduk K, Chloupkova R, Sorejs O, Ecksteinova M, Vitovec M, Cizkova K, Kucera R, Topolcan O.

Neoplasma. 2017;64(4):605-610. doi: 10.4149/neo_2017_416.

PMID:
28485168
26.

Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.

Presl J, Ovesna P, Novotny Z, Vlasak P, Bouda J, Kostun J, Topolcan O, Kucera R, Bednarikova M, Weinberger V.

Anticancer Res. 2017 May;37(5):2697-2702.

PMID:
28476847
27.

MIC1/GDF15 as a Bone Metastatic Disease Biomarker.

Windrichova J, Fuchsova R, Kucera R, Topolcan O, Fiala O, Finek J, Slipkova D.

Anticancer Res. 2017 Mar;37(3):1501-1505.

PMID:
28314325
28.

A Double-Snare Technique for Safe Retrieval of Embolized Left Atrial Appendage Occluders.

Alkhouli M, Aljohani S, Kucera R, Moiduddin N, Hull R.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):e55-e56. doi: 10.1016/j.jcin.2016.12.022. Epub 2017 Feb 15. No abstract available.

29.

Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.

Darebna P, Novak P, Kucera R, Topolcan O, Sanda M, Goldman R, Pompach P.

J Proteomics. 2017 Feb 5;153:44-52. doi: 10.1016/j.jprot.2016.09.004. Epub 2016 Sep 16.

30.

Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.

Kulda V, Topolcan O, Kucera R, Kripnerova M, Srbecka K, Hora M, Hes O, Klecka J, Babuska V, Rousarova M, Benson V, Pesta M.

Anticancer Res. 2016 Sep;36(9):4787-93.

PMID:
27630329
31.

Circulating Growth and Angiogenic Factors and Lymph Node Status in Early-stage Breast Cancer - A Pilot Study.

Karlikova M, Topolcan O, Narsanska A, Kucera R, Treskova I, Treska V.

Anticancer Res. 2016 Aug;36(8):4209-14.

PMID:
27466533
32.

Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.

Fiala O, Pesek M, Finek J, Topolcan O, Racek J, Svaton M, Kucera R, Minarik M, Benesova L, Bortlicek Z, Chloupkova R, Poprach A, Buchler T.

Anticancer Res. 2016 May;36(5):2459-65.

PMID:
27127158
33.

Anti-Müllerian hormone in serum and seminal plasma in comparison with other male fertility parameters.

Kucera R, Ulcova-Gallova Z, Windrichova J, Losan P, Topolcan O.

Syst Biol Reprod Med. 2016 Jun;62(3):223-6. doi: 10.3109/19396368.2016.1161864. Epub 2016 Apr 25.

PMID:
27110929
34.

Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy.

Smid D, Kulda V, Srbecka K, Kubackova D, Dolezal J, Daum O, Kucera R, Topolcan O, Treska V, Skalicky T, Pesta M.

Int J Oncol. 2016 Jun;48(6):2693-703. doi: 10.3892/ijo.2016.3484. Epub 2016 Apr 12.

PMID:
27081844
35.

Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.

Windrichova J, Fuchsova R, Kucera R, Topolcan O, Fiala O, Finek J, Slipkova D, Karlikova M, Svobodova J.

Anticancer Res. 2016 Apr;36(4):1973-8.

PMID:
27069189
36.

Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.

Kucera R, Smid D, Topolcan O, Karlikova M, Fiala O, Slouka D, Skalicky T, Treska V, Kulda V, Simanek V, Safanda M, Pesta M.

Anticancer Res. 2016 Apr;36(4):1967-71.

PMID:
27069188
37.

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.

Fiala O, Pesek M, Finek J, Racek J, Minarik M, Benesova L, Bortlicek Z, Sorejs O, Kucera R, Topolcan O.

Neoplasma. 2016;63(3):471-6. doi: 10.4149/318_151001N512.

PMID:
26952513
38.

The Role of TPS and TPA in the Diagnostics of Distant Metastases.

Kucera R, Topolcan O, Fiala O, Kinkorova J, Treska V, Zedníková I, Slouka D, Simanek V, Safanda M, Babuska V.

Anticancer Res. 2016 Feb;36(2):773-7.

PMID:
26851038
39.

Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy.

Fiala O, Pesek M, Finek J, Svaton M, Sorejs O, Bortlicek Z, Kucera R, Topolcan O.

Anticancer Res. 2016 Jan;36(1):461-6.

PMID:
26722082
40.

Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC.

Fiala O, Pesek M, Finek J, Minarik M, Benesova L, Sorejs O, Svaton M, Bortlicek Z, Kucera R, Topolcan O.

Anticancer Res. 2016 Jan;36(1):455-60.

PMID:
26722081
41.

Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene.

Fiala O, Pesek M, Finek J, Svaton M, Minarik M, Benesova L, Bortlicek Z, Kucera R, Topolcan O.

Anticancer Res. 2016 Jan;36(1):447-53.

PMID:
26722080
42.

Effect of long-term using of hormonal contraception on anti-Müllerian hormone secretion.

Kucera R, Ulcova-Gallova Z, Topolcan O.

Gynecol Endocrinol. 2016;32(5):383-5. doi: 10.3109/09513590.2015.1121981. Epub 2015 Dec 11.

PMID:
26651155
43.

Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).

Hofman J, Kučera R, Neumanova Z, Klimes J, Ceckova M, Staud F.

Xenobiotica. 2016;46(5):416-23. doi: 10.3109/00498254.2015.1086039. Epub 2015 Sep 12.

PMID:
26364927
44.

Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.

Cihalova D, Ceckova M, Kucera R, Klimes J, Staud F.

Biochem Pharmacol. 2015 Dec 1;98(3):465-72. doi: 10.1016/j.bcp.2015.08.099. Epub 2015 Aug 20.

PMID:
26300056
45.

Evaluation of IL-2, IL-6, IL-8 and IL-10 in Malignant Melanoma Diagnostics.

Kucera R, Topolcan O, Treskova I, Kinkorova J, Windrichova J, Fuchsova R, Svobodova S, Treska V, Babuska V, Novak J, Smejkal J.

Anticancer Res. 2015 Jun;35(6):3537-41.

PMID:
26026122
46.

Heteroatom-substituted tetra(3,4-pyrido)porphyrazines: a stride toward near-infrared-absorbing macrocycles.

Vachova L, Machacek M, Kučera R, Demuth J, Cermak P, Kopecky K, Miletin M, Jedlickova A, Simunek T, Novakova V, Zimcik P.

Org Biomol Chem. 2015 May 28;13(20):5608-12. doi: 10.1039/c5ob00651a. Epub 2015 Apr 17.

PMID:
25881971
47.

Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech Republic.

Kucera R, Topolcan O, Pecen L, Kinkorova J, Svobodova S, Windrichova J, Fuchsova R.

Clin Chim Acta. 2015 Apr 15;444:271-7. doi: 10.1016/j.cca.2015.02.036. Epub 2015 Mar 2.

PMID:
25744488
48.

Far-red-absorbing cationic phthalocyanine photosensitizers: synthesis and evaluation of the photodynamic anticancer activity and the mode of cell death induction.

Machacek M, Cidlina A, Novakova V, Svec J, Rudolf E, Miletin M, Kučera R, Simunek T, Zimcik P.

J Med Chem. 2015 Feb 26;58(4):1736-49. doi: 10.1021/jm5014852. Epub 2015 Feb 4.

PMID:
25599409
49.

LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).

Bureš J, Jansová H, Stariat J, Filipský T, Mladěnka P, Šimůnek T, Kučera R, Klimeš J, Wang Q, Franz KJ, Kovaříková P.

J Pharm Biomed Anal. 2015 Feb;105:55-63. doi: 10.1016/j.jpba.2014.11.044. Epub 2014 Dec 3.

50.

Evaluation of IGF1 serum levels in malignant melanoma and healthy subjects.

Kucera R, Treskova I, Vrzalova J, Svobodova S, Topolcan O, Fuchsova R, Rousarova M, Treska V, Kydlicek T.

Anticancer Res. 2014 Sep;34(9):5217-20.

PMID:
25202118

Supplemental Content

Loading ...
Support Center